市場調查報告書

子宮頸癌症診斷檢驗的全球市場

Cervical Cancer Diagnostic Testing

出版商 Global Industry Analysts, Inc. 商品編碼 938819
出版日期 內容資訊 英文 181 Pages
商品交期: 最快1-2個工作天內
價格
子宮頸癌症診斷檢驗的全球市場 Cervical Cancer Diagnostic Testing
出版日期: 2020年05月01日內容資訊: 英文 181 Pages
簡介

全球子宮頸癌症診斷檢驗的市場在新型冠狀病毒感染疾病 (COVID-19)的世界性流行及伴隨而來的經濟不景氣下,預測期間內預計將以4.9%的年複合成長率推移。

調查對象企業範例

  • Abbott Laboratories
  • Arbor Vita Corporation
  • AutoGenomics, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • BioVantra, LLC
  • Cancer Genetics, Inc.
  • Cepheid, Inc.
  • Cytoimmun Diagnostics GmbH
  • Daan Gene Co., Ltd.
  • DiaCarta, Inc.
  • F. Hoffmann-La Roche AG
  • Fujirebio, Inc.
  • Genera Biosystems Ltd.
  • Greiner Bio-One International GmbH
  • Guided Therapeutics, Inc.
  • GynaeHealth
  • Hologic, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Institute
  • OralDNA Labs
  • PreTect AS
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.
  • Roche Molecular Diagnostics
  • Rovers Medical Devices
  • Seegene, Inc.
  • Solopap Australia
  • TrovaGene, Inc.

本報告提供全球子宮頸癌症診斷檢驗的市場調查,彙整市場及產品概要,市場成長的各種影響因素分析,市場規模的變化與預測,各種區分·各地區·各主要國家的詳細分析,競爭環境,主要企業簡介等資訊。

I 簡介·調查手法·調查範圍

II 摘要整理

第1章 市場概要

  • 全球企業佔有率
  • 企業佔有率方案
  • Covid-19的影響·景氣衰退預測

第2章 主要企業

第3章 市場趨勢·成長推進因素

第4章 全球市場的展望

III 市場分析

  • 市場分析:各地區·各主要國家

IV 競爭

  • 企業簡介
目錄
Product Code: MCP10982

Amid the COVID-19 crisis and the looming economic recession, the Cervical Cancer Diagnostic Testing market worldwide will grow by a projected US$2.3 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 4.9%. Pap Smear Test, one of the segments analyzed and sized in this study, is forecast to grow at over 4.2% and reach a market size of US$5.4 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Pap Smear Test market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 3.9% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$68.9 Million to the region's size over the next 7 to 8 years. In addition, over US$70.6 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Pap Smear Test segment will reach a market size of US$294.2 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Cervical Cancer Diagnostic Testing market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 8.1% over the next couple of years and add approximately US$620.2 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Cervical Cancer Diagnostic Testing market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abbott Laboratories; Arbor Vita Corporation; AutoGenomics, Inc.; Becton, Dickinson & Company; bioMerieux SA; BioVantra, LLC; Cancer Genetics, Inc.; Cepheid, Inc.; Cytoimmun Diagnostics GmbH; Daan Gene Co., Ltd.; DiaCarta, Inc.; F. Hoffmann-La Roche AG; Fujirebio, Inc.; Genera Biosystems Ltd.; Greiner Bio-One International GmbH; Guided Therapeutics, Inc.; GynaeHealth; Hologic, Inc.; Micromedic Technologies Ltd.; OncoHealth Institute; OralDNA Labs; PreTect AS; QIAGEN GmbH; Quest Diagnostics, Inc.; Roche Molecular Diagnostics; Rovers Medical Devices; Seegene, Inc.; Solopap Australia; TrovaGene, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Cervical Cancer Diagnostic Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Cervical Cancer Diagnostic Testing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Cervical Cancer Diagnostic Testing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Cervical Cancer Diagnostic Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Pap Smear Test (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Pap Smear Test (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Pap Smear Test (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: HPV Testing (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: HPV Testing (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: HPV Testing (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cervical Cancer Diagnostic Testing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 10: United States Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 11: Cervical Cancer Diagnostic Testing Market in the United States by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 12: United States Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 13: Canadian Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 14: Canadian Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 15: Cervical Cancer Diagnostic Testing Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
  • JAPAN
    • TABLE 16: Japanese Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 17: Cervical Cancer Diagnostic Testing Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 18: Japanese Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 19: Chinese Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 20: Cervical Cancer Diagnostic Testing Historic Market Analysis in China in US$ Million by Test Type: 2012-2019
    • TABLE 21: Chinese Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Cervical Cancer Diagnostic Testing Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 22: European Cervical Cancer Diagnostic Testing Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 23: Cervical Cancer Diagnostic Testing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 24: European Cervical Cancer Diagnostic Testing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 25: European Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 26: Cervical Cancer Diagnostic Testing Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 27: European Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 28: Cervical Cancer Diagnostic Testing Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 29: French Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 30: French Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 31: Cervical Cancer Diagnostic Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 32: German Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 33: German Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 34: Italian Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 35: Cervical Cancer Diagnostic Testing Historic Market Analysis in Italy in US$ Million by Test Type: 2012-2019
    • TABLE 36: Italian Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 38: Cervical Cancer Diagnostic Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 39: United Kingdom Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 40: Spanish Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 41: Spanish Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 42: Cervical Cancer Diagnostic Testing Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
  • RUSSIA
    • TABLE 43: Russian Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 44: Cervical Cancer Diagnostic Testing Market in Russia by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 45: Russian Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 47: Cervical Cancer Diagnostic Testing Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 48: Rest of Europe Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 50: Cervical Cancer Diagnostic Testing Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 51: Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 52: Cervical Cancer Diagnostic Testing Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 53: Asia-Pacific Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 54: Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • AUSTRALIA
    • TABLE 55: Cervical Cancer Diagnostic Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 56: Australian Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 57: Australian Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 58: Indian Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 59: Indian Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
    • TABLE 60: Cervical Cancer Diagnostic Testing Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027
  • SOUTH KOREA
    • TABLE 61: Cervical Cancer Diagnostic Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 62: South Korean Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 63: Cervical Cancer Diagnostic Testing Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 65: Cervical Cancer Diagnostic Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 66: Rest of Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 67: Latin American Cervical Cancer Diagnostic Testing Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 68: Cervical Cancer Diagnostic Testing Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 69: Latin American Cervical Cancer Diagnostic Testing Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 70: Latin American Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 71: Cervical Cancer Diagnostic Testing Historic Market Analysis in Latin America in US$ Million by Test Type: 2012-2019
    • TABLE 72: Latin American Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • ARGENTINA
    • TABLE 73: Argentinean Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 74: Cervical Cancer Diagnostic Testing Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 75: Argentinean Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 76: Cervical Cancer Diagnostic Testing Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 77: Brazilian Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
    • TABLE 78: Brazilian Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • MEXICO
    • TABLE 79: Cervical Cancer Diagnostic Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 80: Mexican Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 81: Mexican Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 83: Cervical Cancer Diagnostic Testing Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 84: Rest of Latin America Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 85: The Middle East Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 86: Cervical Cancer Diagnostic Testing Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 87: The Middle East Cervical Cancer Diagnostic Testing Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 88: The Middle East Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
    • TABLE 89: The Middle East Cervical Cancer Diagnostic Testing Historic Market by Test Type in US$ Million: 2012-2019
    • TABLE 90: Cervical Cancer Diagnostic Testing Market in the Middle East: Percentage Share Breakdown of Sales by Test Type for 2012,2020, and 2027
  • IRAN
    • TABLE 91: Iranian Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
    • TABLE 92: Cervical Cancer Diagnostic Testing Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
    • TABLE 93: Iranian Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 94: Israeli Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
    • TABLE 95: Cervical Cancer Diagnostic Testing Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012-2019
    • TABLE 96: Israeli Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
    • TABLE 98: Cervical Cancer Diagnostic Testing Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012-2019
    • TABLE 99: Saudi Arabian Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED ARAB EMIRATES
    • TABLE 100: Cervical Cancer Diagnostic Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 101: United Arab Emirates Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 102: Cervical Cancer Diagnostic Testing Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 103: Cervical Cancer Diagnostic Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
    • TABLE 104: Rest of Middle East Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
    • TABLE 105: Rest of Middle East Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 106: African Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
    • TABLE 107: Cervical Cancer Diagnostic Testing Market in Africa by Test Type: A Historic Review in US$ Million for 2012-2019
    • TABLE 108: African Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 43